Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization—case study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neurovirology

• Publication date

  2017-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13365-017-0518-zPMID 28247269PMCID PMC5441962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B

  2016cited by this paper
• Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.

  2016cited by this paper
• HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.

  2015cited by this paper
• Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.

  2015cited by this paper
• Variance estimation for nucleotide substitution models.

  2015cited by this paper
• Cerebrospinal fluid can be used for HIV genotyping when it fails in blood.

  2014cited by this paper
• Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil

  2013cited by this paper
• Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States.

  2013cited by this paper
• CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.

  2013cited by this paper
• Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil

  2013cited by this paper
• Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

  2012cited by this paper
• Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.

  2012cited by this paper
• HIV Type 1 Viral Encephalitis After Development of Viral Resistance to Plasma Suppressive Antiretroviral Therapy

  2012cited by this paper
• Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: Case report and review of the literature

  2011cited by this paper
• Tissue-specific HIV-1 infection: why it matters.

  2011cited by this paper
• Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.

  2011cited by this paper
• HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape

  2011cited by this paper
• Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

  2010cited by this paper
• Neurological complications of immune reconstitution in HIV‐infected populations

  2010cited by this paper
• Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.

  2010cited by this paper
• Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136

  2010cited by this paper
• Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection

  2009cited by this paper
• Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS

  2009cited by this paper
• Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

  2009cited by this paper
• Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.

  2007cited by this paper
• Comparative Study of Methods for Detecting Sequence Compartmentalization in Human Immunodeficiency Virus Type 1

  2007cited by this paper
• Immune reconstitution inflammatory syndrome in HIV

  2006cited by this paper
• Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome

  2006cited by this paper
• Neurological complications in AIDS patients receiving HAART: a 2‐year retrospective study

  2006cited by this paper
• Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients

  2006cited by this paper
• Effects of antiretroviral treatment on blood–brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV‐1‐infected patients

  2005cited by this paper
• [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].

  2005cited by this paper
• The International HIV Dementia Scale: a new rapid screening test for HIV dementia

  2005cited by this paper
• Compartmentalized Human Immunodeficiency Virus Type 1 Present in Cerebrospinal Fluid Is Produced by Short-Lived Cells

  2005cited by this paper
• Valeurs usuelles et utilité diagnostique de la β2-microglobuline dans le liquide céphalorachidien

  2005cited by this paper
• Increased Human Immunodeficiency Virus Type 1 (HIV-1) env Compartmentalization in the Presence of HIV-1-Associated Dementia

  2005cited by this paper
• Tat Protein of Human Immunodeficiency Virus Type 1 Subtype C Strains Is a Defective Chemokine

  2004cited by this paper
• MUSCLE: a multiple sequence alignment method with reduced time and space complexity

  2004cited by this paper
• Myelin basic protein in the cerebrospinal fluid of patients infected with HIV

  2004cited by this paper
• Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART

  2004cited by this paper
• A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

  2003cited by this paper
• Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

  2002cited by this paper
• Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

  2002cited by this paper
• Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

  2001cited by this paper
• Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96).

  2000cited by this paper
• External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients.

  1995cited by this paper
• Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

  1994cited by this paper
• Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex.

  1992cited by this paper
• Estimation of levels of gene flow from DNA sequence data.

  1992cited by this paper
• CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel.

  1991cited by this paper
• Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV‐1 do not correlate with CNS disease

  1991cited by this paper
• Predominance of Distinct Viral Genotypes in Brain and Lymph Node Compartments of HIV-1-Infected Individuals

  1991cited by this paper
• Immunoglobulins and complement components in 37 patients infected by HIV-1 virus: comparison of general (systemic) and intrathecal immunity.

  1989cited by this paper
• Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid.

  1989cited by this paper
• Association between intrathecal anti-HIV-1 immunoglobulin G synthesis and occurrence of HIV-1 in cerebrospinal fluid.

  1989cited by this paper
• Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings

  1988cited by this paper
• Intrathecal Synthesis of Anti‐HIV Oligoclonal IgG in HIV‐Seropositive Patients Having No Signs of HIV‐Induced Neurologic Diseases

  1988cited by this paper
• Early penetration of the blood‐brain‐barrier by HIV

  1988cited by this paper
• Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection.

  1988cited by this paper
• CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations.

  1987cited by this paper
• Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex.

  1986cited by this paper
• Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases. An update.

  1983cited by this paper
• Myelin basic protein in CSF and blood. Relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients.

  1982cited by this paper
• Investigation of Reference Values of Components of Cerebrospinal Fluid

  1978cited by this paper
• On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

  1970cited by this paper
• University of California

  1886cited by this paper
• BIOINFORMATICS APPLICATIONS

  year unknowncited by this paper

• HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives

  2025cites this paper
• CD3+CD56+ and CD3-CD56+ lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and C.

  2023cites this paper
• Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana

  2022cites this paper
• Paracoccidioides sp infection impairs central nervous system cell junctional complexes

  2022cites this paper
• The Impact of Paracoccidioides spp Infection on Central Nervous System Cell Junctional Complexes

  2022cites this paper
• HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil

  2021cites this paper
• IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments.

  2021cites this paper
• Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120JRFL

  2021cites this paper
• Improved HIV-1 drug resistance mutation prediction using quasispecies reconstruction supported analysis

  2021cites this paper
• The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs

  2020cites this paper
• Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape

  2020cites this paper
• Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C

  2018cites this paper
• HIV Cerebrospinal Fluid Escape and Neurocognitive Pathology in the Era of Combined Antiretroviral Therapy: What Lies Beneath the Tip of the Iceberg in Sub-Saharan Africa?

  2018influential citation
• Human Immunodeficiency Virus in the Brain—Culprit or Facilitator?

  2018cites this paper
• Quasispecies and virus

  2018cites this paper
• Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics

  2018cites this paper
• Quasispecies and virus

  2018cites this paper
• Gene Therapy Blueprints for NeuroAIDS

  2017cites this paper
• CSF in acute and chronic infectious diseases

  2017cites this paper